NO995692D0 - Nye BPC-peptidsalter med organbeskyttende aktivitet, metoden for deres fremstilling og deres anvendelse - Google Patents

Nye BPC-peptidsalter med organbeskyttende aktivitet, metoden for deres fremstilling og deres anvendelse

Info

Publication number: NO995692D0
Authority: NO; Norway
Prior art keywords: novel; preparation; protective activity; organ protective; peptide salts
Prior art date: 1997-05-23

Application number

NO995692A

Other languages

English (en)

Other versions

NO995692L (no

NO321126B1 (no

Inventor

Predrag Sikiric

Marijan Petek

Sven Seiwerth

Branko Turkovic

Zeljko Grabarevic

Ivo Rotkvic

Stjepan Mise

Marko Duvnjak

Ivan Udovicic

Original Assignee

Predrag Sikiric

Marijan Petek

Sven Seiwerth

Branko Turkovic

Zeljko Grabarevic

Ivo Rotkvic

Stjepan Mise

Marko Duvnjak

Ivan Udovicic

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-05-23

Filing date

1999-11-19

Publication date

1999-11-19

1999-11-19 Application filed by Predrag Sikiric, Marijan Petek, Sven Seiwerth, Branko Turkovic, Zeljko Grabarevic, Ivo Rotkvic, Stjepan Mise, Marko Duvnjak, Ivan Udovicic filed Critical Predrag Sikiric

1999-11-19 Publication of NO995692D0 publication Critical patent/NO995692D0/no

2000-01-24 Publication of NO995692L publication Critical patent/NO995692L/no

2006-03-20 Publication of NO321126B1 publication Critical patent/NO321126B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Toxicology (AREA)
Genetics & Genomics (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Endocrinology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Reproductive Health (AREA)
Zoology (AREA)
Diabetes (AREA)
Psychology (AREA)
Hematology (AREA)
Dermatology (AREA)
Pulmonology (AREA)
Gynecology & Obstetrics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

NO19995692A 1997-05-23 1999-11-19 Salt av et BPC (Body protection compound) "kroppsbeskyttelsesforbindelse"-peptid, omfattende 8 aminosyrerester, kompatibelt, lagringsstabilt, farmasoytisk preparat, diagnostisk lagringsstabilt preparat, anvendelser og fremgangsmater derav. NO321126B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP97108384		1997-05-23
PCT/EP1998/002953 WO1998052973A1 (en)	1997-05-23	1998-05-20	New bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy

Publications (3)

Publication Number	Publication Date
NO995692D0 true NO995692D0 (no)	1999-11-19
NO995692L NO995692L (no)	2000-01-24
NO321126B1 NO321126B1 (no)	2006-03-20

Family

ID=8226822

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19995692A NO321126B1 (no)	1997-05-23	1999-11-19	Salt av et BPC (Body protection compound) "kroppsbeskyttelsesforbindelse"-peptid, omfattende 8 aminosyrerester, kompatibelt, lagringsstabilt, farmasoytisk preparat, diagnostisk lagringsstabilt preparat, anvendelser og fremgangsmater derav.

Country Status (28)

Country	Link
US (1)	US6288028B1 (no)
EP (1)	EP0983300B1 (no)
JP (1)	JP3492381B2 (no)
KR (1)	KR100488038B1 (no)
CN (1)	CN1166683C (no)
AR (1)	AR011478A1 (no)
AT (1)	ATE277948T1 (no)
AU (1)	AU731317B2 (no)
BG (1)	BG64023B1 (no)
BR (1)	BR9809457B1 (no)
CA (1)	CA2290739C (no)
CZ (1)	CZ299423B6 (no)
DE (1)	DE69826653T2 (no)
DK (1)	DK0983300T3 (no)
EA (1)	EA002058B1 (no)
ES (1)	ES2229507T3 (no)
HU (1)	HU227800B1 (no)
ID (1)	ID23184A (no)
IL (2)	IL132884A0 (no)
NO (1)	NO321126B1 (no)
NZ (1)	NZ501323A (no)
PL (1)	PL193790B1 (no)
PT (1)	PT983300E (no)
RS (1)	RS49733B (no)
SK (1)	SK159599A3 (no)
TR (1)	TR199902866T2 (no)
UA (1)	UA61955C2 (no)
WO (1)	WO1998052973A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1731160B1 (en) *	2004-02-27	2012-07-11	Fuji Oil Company, Ltd.	Cancer metastasis inhibitory composition
US8022216B2 (en) *	2007-10-17	2011-09-20	Wyeth Llc	Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
SI24318A (sl)	2013-03-13	2014-09-30	Diagen D.O.O.	Nove stabilne soli pentadekapeptida, postopek za njihovo pripravo, njihova uporaba za izdelavo farmacevtskih pripravkov in njihova uporaba v terapiji
US10350293B2 (en) *	2016-08-23	2019-07-16	Pharmacotherapia d.o.o.	Compositions and methods for treating symptoms associated with multiple sclerosis
MX2020001525A (es)	2017-08-24	2020-03-20	Novo Nordisk As	Composiciones de peptido similar al glucagon tipo 1 (glp-1) y sus usos.
IL294521A (en)	2020-02-18	2022-09-01	Novo Nordisk As	glp-1 compounds and their uses
US11065298B1 (en) *	2020-04-24	2021-07-20	Chanda Zaveri	Compositions and methods for treating or preventing viral infections
US20240382565A1 (en) *	2023-05-15	2024-11-21	Red Mountain Med Spa, LLC	Sublingual semaglutide-bpc 157 combination for weight loss

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2104704C1 (ru) *	1990-09-11	1998-02-20	Сикирич Предраг	Фармакологически активная субстанция защитного соединения организма 3со, способ ее получения и терапевтическое применение
EP0572688B1 (en)	1992-05-30	1997-05-07	Predrag Dr.Sc. Sikiric	Peptides with organo-protective activity, the process for preparing them and their use in therapy
HUT66303A (en)	1992-11-16	1994-11-28	Pliva Pharm & Chem Works	5-thia-1,4-diazabicyclo[4.2.0]oktane-3.8-dioxo-analogues oh beta-lactame, process for producing them, and use of them

1998
- 1998-05-20 IL IL13288498A patent/IL132884A0/xx active IP Right Grant
- 1998-05-20 ID IDW991444A patent/ID23184A/id unknown
- 1998-05-20 SK SK1595-99A patent/SK159599A3/sk unknown
- 1998-05-20 UA UA99127002A patent/UA61955C2/uk unknown
- 1998-05-20 PT PT98929345T patent/PT983300E/pt unknown
- 1998-05-20 EP EP98929345A patent/EP0983300B1/en not_active Expired - Lifetime
- 1998-05-20 HU HU0002329A patent/HU227800B1/hu not_active IP Right Cessation
- 1998-05-20 WO PCT/EP1998/002953 patent/WO1998052973A1/en not_active Ceased
- 1998-05-20 AU AU79141/98A patent/AU731317B2/en not_active Ceased
- 1998-05-20 JP JP54994898A patent/JP3492381B2/ja not_active Expired - Fee Related
- 1998-05-20 ES ES98929345T patent/ES2229507T3/es not_active Expired - Lifetime
- 1998-05-20 EA EA199901061A patent/EA002058B1/ru not_active IP Right Cessation
- 1998-05-20 TR TR1999/02866T patent/TR199902866T2/xx unknown
- 1998-05-20 DK DK98929345T patent/DK0983300T3/da active
- 1998-05-20 KR KR10-1999-7010862A patent/KR100488038B1/ko not_active Expired - Fee Related
- 1998-05-20 CN CNB988053934A patent/CN1166683C/zh not_active Expired - Fee Related
- 1998-05-20 DE DE69826653T patent/DE69826653T2/de not_active Expired - Lifetime
- 1998-05-20 AT AT98929345T patent/ATE277948T1/de active
- 1998-05-20 NZ NZ501323A patent/NZ501323A/en not_active IP Right Cessation
- 1998-05-20 BR BRPI9809457-2A patent/BR9809457B1/pt not_active IP Right Cessation
- 1998-05-20 US US09/424,414 patent/US6288028B1/en not_active Expired - Lifetime
- 1998-05-20 CZ CZ0414299A patent/CZ299423B6/cs not_active IP Right Cessation
- 1998-05-20 PL PL98336897A patent/PL193790B1/pl unknown
- 1998-05-20 RS YUP-601/99A patent/RS49733B/sr unknown
- 1998-05-20 CA CA002290739A patent/CA2290739C/en not_active Expired - Fee Related
- 1998-05-26 AR ARP980102425A patent/AR011478A1/es active IP Right Grant
1999
- 1999-11-11 IL IL132884A patent/IL132884A/en not_active IP Right Cessation
- 1999-11-19 BG BG103905A patent/BG64023B1/bg unknown
- 1999-11-19 NO NO19995692A patent/NO321126B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
CZ299423B6 (cs)	2008-07-23
PL193790B1 (pl)	2007-03-30
NZ501323A (en)	2001-04-27
RS49733B (sr)	2008-04-04
DE69826653D1 (de)	2004-11-04
HU227800B1 (en)	2012-03-28
CA2290739A1 (en)	1998-11-26
JP3492381B2 (ja)	2004-02-03
BR9809457A (pt)	2000-06-20
EA002058B1 (ru)	2001-12-24
UA61955C2 (en)	2003-12-15
HUP0002329A3 (en)	2001-03-28
WO1998052973A1 (en)	1998-11-26
KR20010012895A (ko)	2001-02-26
EP0983300A1 (en)	2000-03-08
ES2229507T3 (es)	2005-04-16
SK159599A3 (en)	2000-11-07
ATE277948T1 (de)	2004-10-15
BG64023B1 (bg)	2003-10-31
NO995692L (no)	2000-01-24
KR100488038B1 (ko)	2005-05-09
EP0983300B1 (en)	2004-09-29
NO321126B1 (no)	2006-03-20
US6288028B1 (en)	2001-09-11
CN1257510A (zh)	2000-06-21
HUP0002329A1 (hu)	2000-12-28
PL336897A1 (en)	2000-07-17
AU7914198A (en)	1998-12-11
PT983300E (pt)	2005-02-28
AU731317B2 (en)	2001-03-29
IL132884A0 (en)	2001-03-19
IL132884A (en)	2007-08-19
JP2000515558A (ja)	2000-11-21
BR9809457B1 (pt)	2010-11-30
ID23184A (id)	2000-03-23
AR011478A1 (es)	2000-08-16
YU60199A (sh)	2002-09-19
DE69826653T2 (de)	2006-03-09
CZ9904142A3 (cs)	2002-03-13
BG103905A (en)	2000-07-31
CN1166683C (zh)	2004-09-15
DK0983300T3 (da)	2005-01-31
EA199901061A1 (ru)	2000-06-26
TR199902866T2 (xx)	2000-02-21
CA2290739C (en)	2007-06-26

Publication	Publication Date	Title
DK0910647T3 (da)	2008-07-21	Human DNase i hyperaktive varianter
BR9406720A (pt)	1996-02-06	Utilização de um adenovírus recombinante de origem animal adenovírus recombinante de origem animal e composição farmacêutica compreendendo um ou vários adenovírus
ATE198050T1 (de)	2000-12-15	Therapeutische anwendungen von bpi-protein- produkten zur behandlung von humaner meningococcämia
DK1546127T3 (da)	2007-12-10	Nye pyrimidinamidderivater og anvendelse deraf
BR9610480A (pt)	1999-03-16	Inibição do fator alfa de necrose tumoral
FI940375A0 (fi)	1994-01-26	Peptidit, joilla on elimiä suojaavaa vaikutusta, menetelmä niiden valmistamiseksi ja niiden käyttö terapiassa
MXPA05008704A (es)	2005-10-05	Proteinas de fusion de muteinas de interferon alfa con propiedades mejoradas.
NO995692D0 (no)	1999-11-19	Nye BPC-peptidsalter med organbeskyttende aktivitet, metoden for deres fremstilling og deres anvendelse
TR200100637T2 (tr)	2001-10-22	Yeni doğal ürün türevleri
DE69939075D1 (de)	2008-08-21	Pharmazeutische Zusammenstellung zur Vorbeugung und Behandlung von mit Zellkrankheiten des Augenhintergrundes zusammenhängenden Krankheiten
DE69833876D1 (de)	2006-05-11	Zusammensetzungen und methoden zur zielgerichteten abgabe von biologisch aktivenfaktoren
ATE313561T1 (de)	2006-01-15	Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen
TR199901385T2 (xx)	1999-11-22	Piperidin t�revleri.
DK0821969T3 (da)	2007-03-26	Medicinsk sammensætning omfattende TCF-II
NO952601L (no)	1996-01-02	Oligonukleotider for inhibering av ekspresjon av isoprenylprotein-transferaser
AP2009004857A0 (en)	2009-06-30	Oxidized proteins, their biological activity, and therapeutic and diagnostic measures,which are derived from the active mechanism, from the use of these proteins or from the inhibition thereof
DE3769497D1 (de)	1991-05-29	Mittel zur bekaempfung von phytopathogenen mikroben.
DK0811068T3 (da)	2003-03-10	Humane DNase I varianter
ES2181160T3 (es)	2003-02-16	Derivados de 1,4-dihidropiridina y su utilizacion en terapia.
ATE338560T1 (de)	2006-09-15	Pharmazeutische zusammentsetzung zur medizinischen behandlung von gutartiger prostathyperplasie, dessen vorbereitungsmethode und dessen therapeutische verwendung
DE60030593D1 (de)	2006-10-19	Labdan-enthaltende arzneiformulierungen zur behandlung von tumoren oder leukämien

Legal Events

Date	Code	Title	Description
2017-12-27	MM1K	Lapsed by not paying the annual fees